FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310947202> ?p ?o ?g. }

• W4310947202 endingPage "927" @default.
• W4310947202 startingPage "918" @default.
• W4310947202 abstract "Abstract Introduction As the science base around the potential benefits of a reduced-nicotine standard for cigarettes grows, information on the potential effects on adolescent smokers is a high priority. The aim of this randomized trial was to test the influence of 3-week exposure to reduced nicotine cigarettes in a sample of adolescent daily smokers. Aims and Methods In this double-blind, two-arm, randomized controlled trial (NCT0258731), following a 1-week baseline, adolescent daily smokers not currently intending to quit (ages 15–19 years, n = 66 randomized) were urn randomized to use either very low nicotine content (VLNC; 0.4 mg/g; n = 33) or normal nicotine content (NNC, 15.8 mg/g; n = 33) research cigarettes for 3 weeks. Participants attended five study sessions at our clinical laboratory. The primary outcome was average total cigarettes smoked per day (CPD; including both study and non-study cigarettes) at week 3. Results Stepwise regression results demonstrated that compared with NNC cigarettes (n = 31), assignment to VLNC cigarettes (n = 29), was associated with 2.4 fewer CPD on average than NNC assignment (p &lt; .05) week 3 when controlling for covariates (p &lt; .01, Cohen’s d = 0.52 n = 60 completed all procedures). VLNC cigarettes were also associated with lower levels of craving reduction than NNC cigarettes (Questionnaire on Smoking Urges Factor 2, p &lt; .05). No group differences were found for secondary outcomes. Conclusions Adolescent participants assigned to VLNC use for 3 weeks smoked fewer total CPD relative to the NNC group. Overall, data suggest that a VLNC policy would reduce cigarette smoking in adolescents who smoke, but high rates of incomplete adherence suggest that youth may seek alternative sources of nicotine in this scenario. Implications The US Food and Drug Administration may enact a reduced-nicotine product standard that would affect all commercially available cigarettes. One important population affected by this policy would be adolescents who smoke. This study, the first clinical trial of VLNC cigarettes in adolescents, demonstrates that adolescents switched to VLNC cigarettes for 3 weeks reduced their CPD relative to the normal-nicotine cigarette control group, without leading to increased respiratory symptoms or increased withdrawal. Biomarkers indicated the use of other sources of nicotine, suggesting that such a policy will need to consider approaches to assist in transitioning away from smoking." @default.
• W4310947202 created "2022-12-21" @default.
• W4310947202 creator A5000146961 @default.
• W4310947202 creator A5001054998 @default.
• W4310947202 creator A5017049621 @default.
• W4310947202 creator A5022126431 @default.
• W4310947202 creator A5048526055 @default.
• W4310947202 creator A5054433219 @default.
• W4310947202 creator A5054900149 @default.
• W4310947202 creator A5080778481 @default.
• W4310947202 date "2022-12-09" @default.
• W4310947202 modified "2023-09-26" @default.
• W4310947202 title "The Impact of Reducing Nicotine Content on Adolescent Cigarette Smoking and Nicotine Exposure: Results From a Randomized Controlled Trial" @default.
• W4310947202 cites W1982427707 @default.
• W4310947202 cites W1982969180 @default.
• W4310947202 cites W1984980793 @default.
• W4310947202 cites W1994812591 @default.
• W4310947202 cites W2031883949 @default.
• W4310947202 cites W2031979913 @default.
• W4310947202 cites W2039460330 @default.
• W4310947202 cites W2062625542 @default.
• W4310947202 cites W2074241539 @default.
• W4310947202 cites W2077348308 @default.
• W4310947202 cites W2082056906 @default.
• W4310947202 cites W2082456903 @default.
• W4310947202 cites W2083832226 @default.
• W4310947202 cites W2089338173 @default.
• W4310947202 cites W2110569081 @default.
• W4310947202 cites W2118061336 @default.
• W4310947202 cites W2129274318 @default.
• W4310947202 cites W2146698414 @default.
• W4310947202 cites W2148905283 @default.
• W4310947202 cites W2155519999 @default.
• W4310947202 cites W2158154049 @default.
• W4310947202 cites W2169463741 @default.
• W4310947202 cites W2269911282 @default.
• W4310947202 cites W2395414713 @default.
• W4310947202 cites W2421132628 @default.
• W4310947202 cites W2422972976 @default.
• W4310947202 cites W2559005774 @default.
• W4310947202 cites W2581313612 @default.
• W4310947202 cites W2590155104 @default.
• W4310947202 cites W2746492940 @default.
• W4310947202 cites W2779308133 @default.
• W4310947202 cites W2793246238 @default.
• W4310947202 cites W2795514444 @default.
• W4310947202 cites W2801141217 @default.
• W4310947202 cites W2804376785 @default.
• W4310947202 cites W2891062653 @default.
• W4310947202 cites W2912338138 @default.
• W4310947202 cites W2914910041 @default.
• W4310947202 cites W2997005163 @default.
• W4310947202 cites W2997410539 @default.
• W4310947202 cites W2998440651 @default.
• W4310947202 cites W3003360162 @default.
• W4310947202 cites W3008215799 @default.
• W4310947202 cites W3040117876 @default.
• W4310947202 cites W3090640228 @default.
• W4310947202 cites W3093221611 @default.
• W4310947202 cites W3111880864 @default.
• W4310947202 cites W3118809430 @default.
• W4310947202 cites W3136520242 @default.
• W4310947202 doi "https://doi.org/10.1093/ntr/ntac279" @default.
• W4310947202 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36482794" @default.
• W4310947202 hasPublicationYear "2022" @default.
• W4310947202 type Work @default.
• W4310947202 citedByCount "1" @default.
• W4310947202 countsByYear W43109472022023 @default.
• W4310947202 crossrefType "journal-article" @default.
• W4310947202 hasAuthorship W4310947202A5000146961 @default.
• W4310947202 hasAuthorship W4310947202A5001054998 @default.
• W4310947202 hasAuthorship W4310947202A5017049621 @default.
• W4310947202 hasAuthorship W4310947202A5022126431 @default.
• W4310947202 hasAuthorship W4310947202A5048526055 @default.
• W4310947202 hasAuthorship W4310947202A5054433219 @default.
• W4310947202 hasAuthorship W4310947202A5054900149 @default.
• W4310947202 hasAuthorship W4310947202A5080778481 @default.
• W4310947202 hasConcept C118552586 @default.
• W4310947202 hasConcept C126322002 @default.
• W4310947202 hasConcept C142724271 @default.
• W4310947202 hasConcept C168563851 @default.
• W4310947202 hasConcept C2777843972 @default.
• W4310947202 hasConcept C2778647338 @default.
• W4310947202 hasConcept C2779541405 @default.
• W4310947202 hasConcept C2779547902 @default.
• W4310947202 hasConcept C48856860 @default.
• W4310947202 hasConcept C71924100 @default.
• W4310947202 hasConceptScore W4310947202C118552586 @default.
• W4310947202 hasConceptScore W4310947202C126322002 @default.
• W4310947202 hasConceptScore W4310947202C142724271 @default.
• W4310947202 hasConceptScore W4310947202C168563851 @default.
• W4310947202 hasConceptScore W4310947202C2777843972 @default.
• W4310947202 hasConceptScore W4310947202C2778647338 @default.
• W4310947202 hasConceptScore W4310947202C2779541405 @default.
• W4310947202 hasConceptScore W4310947202C2779547902 @default.
• W4310947202 hasConceptScore W4310947202C48856860 @default.
• W4310947202 hasConceptScore W4310947202C71924100 @default.
• W4310947202 hasFunder F4320332161 @default.

• next